JPMORGAN CHASE & CO - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 31 filers reported holding ETON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$20,629
-26.3%
5,911
-55.5%
0.00%
Q3 2022$28,000
+154.5%
13,278
+221.9%
0.00%
Q2 2022$11,000
-89.6%
4,125
-83.0%
0.00%
Q1 2022$106,000
+10500.0%
24,273
+15764.7%
0.00%
Q2 2021$1,000
-97.9%
153
-97.6%
0.00%
Q1 2021$47,000
-81.5%
6,404
-79.5%
0.00%
Q4 2020$254,000
+225.6%
31,268
+213.1%
0.00%
Q3 2020$78,000
+27.9%
9,985
-10.6%
0.00%
Q2 2020$61,00011,1710.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders